Summary of share price highs, lows and changes for Dexco
Historical stock prices
Current Share Price	R$5.08
52 Week High	R$7.92
52 Week Low	R$4.96
Beta	0.36
1 Month Change	-3.24%
3 Month Change	-10.25%
1 Year Change	-33.51%
3 Year Change	-31.01%
5 Year Change	-67.27%
Change since IPO	-31.87%

Recent updates

Earnings Troubles May Signal Larger Issues for Dexco (BVMF:DXCO3) Shareholders

Nov 13

Does Dexco (BVMF:DXCO3) Have A Healthy Balance Sheet?

Oct 06

Dexco's (BVMF:DXCO3) Anemic Earnings Might Be Worse Than You Think

Mar 21

Dexco S.A. Just Missed Earnings - But Analysts Have Updated Their Models

Mar 15

New Ceramic Tiles Factory In Botucatu Will Improve Future Operations

Mar 10 Streamlining of operations could enhance focus on core areas, boosting profitability and improving net margins.

Here's Why Dexco (BVMF:DXCO3) Has A Meaningful Debt Burden

Feb 12

Is Dexco S.A. (BVMF:DXCO3) Potentially Undervalued?

Dec 20

There's Reason For Concern Over Dexco S.A.'s (BVMF:DXCO3) Price

Dec 02

Is Dexco (BVMF:DXCO3) A Risky Investment?

Oct 26

Analysts Are Updating Their Dexco S.A. (BVMF:DXCO3) Estimates After Its Second-Quarter Results

Aug 10

Why Dexco S.A. (BVMF:DXCO3) Could Be Worth Watching

Aug 08

Returns On Capital At Dexco (BVMF:DXCO3) Have Stalled

Jul 19

Earnings Miss: Dexco S.A. Missed EPS And Analysts Are Revising Their Forecasts

May 13

Is It Time To Consider Buying Dexco S.A. (BVMF:DXCO3)?

May 04

Slowing Rates Of Return At Dexco (BVMF:DXCO3) Leave Little Room For Excitement

Apr 15

Dexco's (BVMF:DXCO3) Earnings Might Not Be As Promising As They Seem

Mar 14

Dexco S.A.'s (BVMF:DXCO3) Earnings Are Not Doing Enough For Some Investors

Jan 19

Dexco (BVMF:DXCO3) Has A Somewhat Strained Balance Sheet

Jan 04

At R$7.43, Is Dexco S.A. (BVMF:DXCO3) Worth Looking At Closely?

Dec 04

Returns Are Gaining Momentum At Dexco (BVMF:DXCO3)

Oct 08

Is Dexco (BVMF:DXCO3) A Risky Investment?

Sep 13

Returns At Dexco (BVMF:DXCO3) Are On The Way Up

Jun 22

Does Dexco (BVMF:DXCO3) Have A Healthy Balance Sheet?

May 31

We Like These Underlying Return On Capital Trends At Dexco (BVMF:DXCO3)

Mar 10

We Think Dexco (BVMF:DXCO3) Is Taking Some Risk With Its Debt

Feb 13

Dexco (BVMF:DXCO3) Might Have The Makings Of A Multi-Bagger

Dec 02

We Think Dexco (BVMF:DXCO3) Is Taking Some Risk With Its Debt

Nov 13

Is Now The Time To Look At Buying Dexco S.A. (BVMF:DXCO3)?

Oct 11

Shareholder Returns

	DXCO3	BR Forestry	BR Market
7D	-5.2%	-2.3%	-1.1%
1Y	-33.5%	-19.2%	9.8%

Return vs Industry: DXCO3 underperformed the BR Forestry industry which returned -18.1% over the past year.

Return vs Market: DXCO3 underperformed the BR Market which returned 9.7% over the past year.

Price Volatility

Is DXCO3's price volatile compared to industry and market?
DXCO3 volatility
DXCO3 Average Weekly Movement	4.2%
Forestry Industry Average Movement	4.3%
Market Average Movement	4.1%
10% most volatile stocks in BR Market	8.8%
10% least volatile stocks in BR Market	2.1%

Stable Share Price: DXCO3 has not had significant price volatility in the past 3 months compared to the BR market.

Volatility Over Time: DXCO3's weekly volatility (4%) has been stable over the past year.

About the Company

Founded	Employees	CEO	Website
1951	n/a	Antonio de Oliveira	ri.dex.co

Dexco S.A., together with its subsidiaries, engages in the production and sale of wooden panels in Brazil and internationally. It operates through Wood, Deca, and Coatings segments. The company offers medium density particulate panels, and medium and high-density fiberboard panels under the Duratex brand; laminated floors and semifinished components for furniture under the Durafloor brand name; and vitreous chinaware, sanitary ware and metals, under the Deca, Hydra, Belize, Elizabeth, and Hydra Corona brands.

Dexco S.A. Fundamentals Summary

How do Dexco's earnings and revenue compare to its market cap?
DXCO3 fundamental statistics
Market cap	R$4.13b
Earnings (TTM)	R$111.15m
Revenue (TTM)	R$8.22b

37.0x

P/E Ratio

0.5x

P/S Ratio

Is DXCO3 overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
DXCO3 income statement (TTM)
Revenue	R$8.22b
Cost of Revenue	R$6.31b
Gross Profit	R$1.91b
Other Expenses	R$1.80b
Earnings	R$111.15m

Last Reported Earnings

Sep 30, 2025

Next Earnings Date

n/a

Earnings per share (EPS)	0.14
Gross Margin	23.26%
Net Profit Margin	1.35%
Debt/Equity Ratio	101.8%

How did DXCO3 perform over the long term?

See historical performance and comparison

Dividends

4.2%

Current Dividend Yield

52%

Payout Ratio

Does DXCO3 pay a reliable dividends?

See DXCO3 dividend history and benchmarks

When do you need to buy DXCO3 by to receive an upcoming dividend?
Dexco dividend dates
Ex Dividend Date	Dec 19 2024
Dividend Pay Date	Dec 31 2025
Days until Ex dividend	341 days
Days until Dividend pay date	36 days

Does DXCO3 pay a reliable dividends?

See DXCO3 dividend history and benchmarks

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/11/24 06:28
End of Day Share Price	2025/11/24 00:00
Earnings	2025/09/30
Annual Earnings	2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Dexco S.A. is covered by 16 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Guilherme Rosito	BofA Global Research
Rafael Barcellos	Bradesco S.A. Corretora de Títulos e Valores Mobiliários
Leonardo Correa	BTG Pactual

Dexco (DXCO3) Stock Overview

Rewards

Risk Analysis

Volatile Latin America And ESG Pressures Will Undermine Wood Revenues

Urbanization Trends And Digital Platforms Will Expand Market Reach

Urbanization, Sustainability, And Digital Channels Will Expand Construction Markets

Dexco S.A. Competitors

Eucatex Indústria e Comércio

Companhia Brasileira de Alumínio

Cia de Ferro Ligas da Bahia - FERBASA

Unipar Carbocloro

Price History & Performance

Recent News & Updates

Earnings Troubles May Signal Larger Issues for Dexco (BVMF:DXCO3) Shareholders

Third quarter 2025 earnings released: EPS: R$0.013 (vs R$0.11 in 3Q 2024)

Consensus EPS estimates increase by 21%

Does Dexco (BVMF:DXCO3) Have A Healthy Balance Sheet?

Consensus EPS estimates increase by 45%

Recent updates

Earnings Troubles May Signal Larger Issues for Dexco (BVMF:DXCO3) Shareholders

Third quarter 2025 earnings released: EPS: R$0.013 (vs R$0.11 in 3Q 2024)

Consensus EPS estimates increase by 21%

Does Dexco (BVMF:DXCO3) Have A Healthy Balance Sheet?

Consensus EPS estimates increase by 45%

Consensus EPS estimates fall by 83%

Consensus EPS estimates increase by 70%

Consensus EPS estimates increase by 72%

Consensus EPS estimates fall by 73%

Now 20% undervalued after recent price drop

First quarter 2025 earnings: EPS and revenues miss analyst expectations

Consensus EPS estimates fall by 17%

Dexco S.A., Annual General Meeting, Apr 24, 2025

Now 23% undervalued after recent price drop

Dexco's (BVMF:DXCO3) Anemic Earnings Might Be Worse Than You Think

New minor risk - Earnings quality

Consensus EPS estimates fall by 12%

Dexco S.A. announces Annual dividend, payable on December 31, 2025

Dexco S.A. Just Missed Earnings - But Analysts Have Updated Their Models

Full year 2024 earnings: Revenues exceed analyst expectations

Dexco S.A. to Report Q1, 2025 Results on May 07, 2025

New Ceramic Tiles Factory In Botucatu Will Improve Future Operations

Now 22% undervalued after recent price drop

New minor risk - Earnings quality

Dexco S.A. to Report Q4, 2024 Results on Mar 12, 2025

Here's Why Dexco (BVMF:DXCO3) Has A Meaningful Debt Burden

Now 20% undervalued after recent price drop

Consensus EPS estimates fall by 30%

Is Dexco S.A. (BVMF:DXCO3) Potentially Undervalued?

Consensus EPS estimates fall by 21%

There's Reason For Concern Over Dexco S.A.'s (BVMF:DXCO3) Price

Consensus EPS estimates increase by 28%

New minor risk - Profit margin trend

Third quarter 2024 earnings: Revenues exceed analyst expectations

Is Dexco (BVMF:DXCO3) A Risky Investment?

Consensus EPS estimates fall by 14%

Dexco S.A.(BOVESPA:DXCO3) dropped from FTSE All-World Index (USD)

Consensus EPS estimates fall by 16%

Analysts Are Updating Their Dexco S.A. (BVMF:DXCO3) Estimates After Its Second-Quarter Results

Second quarter 2024 earnings: EPS in line with analyst expectations despite revenue beat

Why Dexco S.A. (BVMF:DXCO3) Could Be Worth Watching

Returns On Capital At Dexco (BVMF:DXCO3) Have Stalled

Consensus EPS estimates increase by 13%

Consensus EPS estimates increase by 13%

Consensus EPS estimates increase by 13%

Consensus EPS estimates increase by 13%

Earnings Miss: Dexco S.A. Missed EPS And Analysts Are Revising Their Forecasts

First quarter 2024 earnings: EPS and revenues miss analyst expectations

Consensus EPS estimates fall by 26%

Is It Time To Consider Buying Dexco S.A. (BVMF:DXCO3)?

Consensus EPS estimates fall by 37%, revenue upgraded

Slowing Rates Of Return At Dexco (BVMF:DXCO3) Leave Little Room For Excitement

Dexco's (BVMF:DXCO3) Earnings Might Not Be As Promising As They Seem

Consensus EPS estimates increase by 19%, revenue downgraded

New minor risk - Earnings quality

New minor risk - Share price stability

Full year 2023 earnings: EPS exceeds analyst expectations

Now 25% overvalued after recent price rise

Dexco S.A. to Report Q4, 2023 Results on Mar 06, 2024

Dexco S.A.'s (BVMF:DXCO3) Earnings Are Not Doing Enough For Some Investors

Dexco S.A., Annual General Meeting, Apr 26, 2024